Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-21-001520)

Filing Details

Accession Number:: 0001214659-21-001520
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-10 20:17:36
Reporting Period:: 2021-02-09

Accepted Time:: 2021-02-10 20:17:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1398733	Aquestive Therapeutics Inc.	AQST	Pharmaceutical Preparations (2834)	208623253

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406836	Mark Alexander Schobel	C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059	Chief Innovation/Tech Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-09	11,540	$6.75	860,460	No	4	S	Direct
Common Stock	Disposition	2021-02-10	23,460	$6.75	837,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.